Evidence map›Paper›PMID 38561676›Full record

SynthesisBMC primary care2024

Involving community pharmacists in interprofessional collaboration in primary care: a systematic review.

Morgane Angibaud, Maud Jourdain, Solene Girard, Louise Rouxel, Adam Mouhib, Antoine Nogueira, Cédric Rat, Jean-François Huon

Abstract readSystematic Review
In one paragraph

Synthesis in BMC primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Morgane AngibaudPrimary Care Federative Department, Faculty of Medicine, Nantes Université, Nantes, France. morgane.angibaud@univ-nantes.fr.
Maud JourdainDepartment of General Practice, Faculty of Medicine, Nantes Université, Nantes, France.
Solene GirardDepartment of General Practice, Faculty of Medicine, Nantes Université, Nantes, France.
Louise RouxelDepartment of General Practice, Faculty of Medicine, Nantes Université, Nantes, France.
Adam MouhibClinical Pharmacy Unit, Faculty of Pharmacy, Nantes Université, Nantes, France.
Antoine NogueiraDepartment of General Practice, Faculty of Medicine, Nantes Université, Nantes, France.
Cédric Rat *National Institute for Health and Medical Research, INSERM U1302 Team 2, INCIT, Team 2, Nantes, France.
Jean-François Huon *Nantes Université, CHU Nantes, Pharmacie, F-44000, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe World Health Organization supports interprofessional collaboration in primary care. On over the past 20 years, community pharmacists had been taking a growing number of new responsibilities and they are recognized as a core member of collaborative care teams as patient-centered care providers. This systematic review aimed to describe interprofessional collaboration in primary care involving a pharmacist, and its effect on patient related outcomes.

methodsA systematic review of randomized controlled trials cited in the MEDLINE, EMBASE, PsycInfo and CINAHL in English and French was conducted from inception to November 2022. Studies were included if they described an intervention piloted by a primary care provider and included a pharmacist and if they evaluated the effects of intervention on a disease or on patient related outcomes. The search generated 3494 articles. After duplicates were removed and titles and abstracts screened for inclusion, 344 articles remained.

resultsOverall, 19 studies were included in the review and assessed for quality. We found 14 studies describing an exclusive collaboration between physician and pharmacist with for all studies a three-step model of pharmacist intervention: a medication review, an interview with the patient, and recommendations made to physician. Major topics in the articles eligible for inclusion included cardiovascular diseases with blood pressure, diabetes, dyslipidemia, and risk of cardiovascular diseases. Positive effects concerned principally blood pressure.

conclusionsCollaboration involving pharmacists is mainly described in relation to cardiovascular diseases, for which patient-centered indicators are most often positive. It underscores the need for further controlled studies on pharmacist-involved interprofessional collaboration across various medical conditions to improve consensus on core outcomes measures.

Indexed as

Interprofessional RelationsPatient Care TeamPharmacistsPrimary Health CareCommunity Pharmacy ServicesCooperative BehaviorHumansPatient-Centered CareProfessional RoleCollaborative practiceCommunity pharmacistPrimary care

Identifiers

PMID38561676
PMCPMC10983710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.